Supportive Care in Cancer

, Volume 24, Issue 11, pp 4815–4824 | Cite as

Self-reported oral health and quality of life of postmenopausal breast cancer survivors on aromatase inhibitors and women without cancer diagnoses: a longitudinal analysis

  • L. Susan Taichman
  • Catherine H. Van Poznak
  • Marita R. Inglehart
Original Article



Aromatase inhibitors (AIs) are a well-established component of adjuvant therapy in postmenopausal women with hormone receptor (HR) + early stage breast cancer (BCa). We explored in an 18-month cohort study whether subjective oral health (OH), subjective periodontal health (PH), and oral health-related quality of life (OHRQoL) of postmenopausal BCa survivors on AIs differ from those of women without cancer diagnoses, and whether saliva flow, OH, PH, and OHRQoL are related.


Data were collected from 29 postmenopausal BCa survivors on AIs and 29 postmenopausal women without cancer diagnoses. Socio-demographic information, OH, PH, and OHRQoL were collected at baseline and 6, 12, and 18 months later. Unstimulated whole saliva volume per 15 min was determined by drooling.


The two groups did not differ in background characteristics at baseline. Women on AIs had poorer OH (p = .043), PH (p = .04), and OHRQoL (p = .017), and lower saliva flow rate (p < .001) than control respondents. BCa survivors had the poorest PH at the 18-month visit. Xerostomia was correlated with OH at baseline and with OH and PH at 18 months. However, objective saliva flow rate was not correlated with OH or OHRQoL at this visit.


This study is the first to investigate the effects of AIs on patients’ subjective OH, subjective PH, and OHRQoL. The data suggest that women treated with AIs have worse OH, PH, and OHRQoL than women without cancer diagnoses. Interprofessional care is recommended so that women on AIs receive optimal supportive oral care to assure long-term OH and positive OHRQoL.

Trial registration NCT01272570


Oral health Periodontitis Quality of life Aromatase inhibitors Breast neoplasms Saliva 


  1. 1.
    Gift HC, Atchison KA (1995) Oral health, health, and health-related quality of life. Med Care 33:57–77CrossRefGoogle Scholar
  2. 2.
    Borgnakke WS, Ylostalo PV, Taylor GW, Genco RJ (2013) Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Clin Periodontol 40:S135–S152CrossRefPubMedGoogle Scholar
  3. 3.
    Brennan DS, Teusner DN (2015) Oral health impacts on self-rated general and oral health in a cross-sectional study of working age adults. Community Dent Oral Epidemiol 43:282–288CrossRefPubMedGoogle Scholar
  4. 4.
    Epstein JB, Murphy BA (2010) Late effects of cancer and cancer therapy on oral health and quality of life. J Mass Dent Soc 59:22–27PubMedGoogle Scholar
  5. 5.
    Ohrn K (2002) The role of oral sequelae in health-related quality of life of cancer patients. Support Care Cancer 10:656–658CrossRefPubMedGoogle Scholar
  6. 6.
    Al-Ansari S, Zecha JA, Barasch A, de Lange J, Rozema FR, Raber-Durlacher JE (2015) Oral mucositis induced by anticancer therapies. Curr Oral Health Rep 2:202–211CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sonis ST, Fey EG (2002) Oral complications of cancer therapy. Oncology (Williston Park) 16:680–686 discussion 86, 91-2, 95Google Scholar
  8. 8.
    Mosel DD, Bauer RL, Lynch DP, Hwang ST (2011) Oral complications in the treatment of cancer patients. Oral Dis 17:550–559CrossRefPubMedGoogle Scholar
  9. 9.
    Almazrooa SA, Woo SB (2009) Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review. J Am Dent Assoc 140:864–875CrossRefPubMedGoogle Scholar
  10. 10.
    Hong CH, Napenas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT, Dental Disease Section, Oral Care Study Group, Multi-national Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) (2010) A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 18:1007–1021CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AJ, Guiot HF, van der Velden U (2002) Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 10:466–473CrossRefPubMedGoogle Scholar
  12. 12.
    AlJehani YA (2014) Risk factors of periodontal disease: review of the literature. Int J Dent 2014:182513PubMedPubMedCentralGoogle Scholar
  13. 13.
    Haverman TM, Raber-Durlacher JE, Rademacher WM, Vokurka S, Epstein JB, Huisman C, Hazenberg MD, de Soet JJ, de Lange J, Rozema FR (2014) Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediat Inflamm 2014:378281CrossRefGoogle Scholar
  14. 14.
    Vozza I, Caldarazzo V, Polimeni A, Ottolenghi L (2015) Periodontal disease and cancer patients undergoing chemotherapy. Int Dent 65:45–48CrossRefGoogle Scholar
  15. 15.
    Bueno AC, Ferreira RC, Barbosa FI, Ham BC, Magalhaes CS, Moreira AN (2013) Periodontal care in patients undergoing radiotherapy for head and neck cancer. Support Care Cancer 21:969–975CrossRefPubMedGoogle Scholar
  16. 16.
    Fernandes LL, Torres SR, Garnica M, de Souza Gonçalves L, Junior AS, de Vasconcellos ÁC, Cavalcanti W, Maiolino A, de Barros Torres MC (2014) Oral status of patients submitted to autologous hematopoietic stem cell transplantation. Support Care Cancer 22:15–21CrossRefPubMedGoogle Scholar
  17. 17.
    American Cancer Society. Cancer Facts & Figures 2015. Atlanta 2015 Available at: Accessed 26 Jan 2016
  18. 18.
    Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MF, Stearns V, Winer EP, Somerfield MR, Griggs JJ (2010) American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28:3784–3796CrossRefPubMedGoogle Scholar
  19. 19.
    Eastell R, Adams JE, Coleman RE, Howell A, Hannon RA, Cuzick J, Mackey JR, Beckmann MW, Clack G (2008) Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol 26:1051–1057CrossRefPubMedGoogle Scholar
  20. 20.
    Montazeri A, Gillis CR, McEwen J (1996) Measuring quality of life in oncology: is it worthwhile? I. Meaning, purposes and controversies. Eur J Cancer Care 5:159–167CrossRefGoogle Scholar
  21. 21.
    Olufade T, Gallicchio L, MacDonald R, Helzlsouer KJ (2015) Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors. Support Care Cancer 23:447–455CrossRefPubMedGoogle Scholar
  22. 22.
    Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E (2012) A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms. Breast Cancer Res Treat 131:277–285CrossRefPubMedGoogle Scholar
  23. 23.
    Fallowfield L, Cella D, Cuzick J, et al. (2004) Quality of life of postmenopausal women in the Arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22:4261–4471CrossRefPubMedGoogle Scholar
  24. 24.
    Inglehart MR, Bagramian RA (2002) Oral health related quality of life. Quintessence Publishing, Inc, ChicagoGoogle Scholar
  25. 25.
    Rathbone EJ, Brown JE, Marshall HC, et al. (2013) Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04). J Clin Oncol 31:2685–2691CrossRefPubMedGoogle Scholar
  26. 26.
    Taichman LS, Inglehart MR, Giannobile WV, Kolenic G, van Poznak C (2015) Periodontal health in women with early-stage postmenopausal breast cancer newly on aromatase inhibitors: a pilot study. J Periodontol 86:906–916CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Sheiham A (2001) Dietary effects on dental diseases. Public Health Nutr 4(2B):569–591CrossRefPubMedGoogle Scholar
  28. 28.
    Lee IC, Shieh TY, Yang YH, Tsai CC, Wang KH (2007) Individuals' perception of oral health and its impact on the health-related quality of life. J Oral Rehabil 34:79–87CrossRefPubMedGoogle Scholar
  29. 29.
    Marino R, Schofield M, Wright C, Calache H, Minichiello V (2008) Self-reported and clinically determined oral health status predictors for quality of life in dentate older migrant adults. Community Dent Oral Epidemiol 36:85–94PubMedGoogle Scholar
  30. 30.
    Locker D (2004) Oral health and quality of life. Oral Health Prev Dent 2(Suppl 1):247–253PubMedGoogle Scholar
  31. 31.
    Sheiham A, Steele JG, Marcenes W, Finch S, Walls AW (1999) The impact of oral health on stated ability to eat certain foods; findings from the National Diet and Nutrition Survey of older people in Great Britain. Gerodontology 16:11–20CrossRefPubMedGoogle Scholar
  32. 32.
    Enoki K, Matsuda KI, Ikebe K, Murai S, Yoshida M, Maeda Y, Thomson WM (2014) Influence of xerostomia on oral health-related quality of life in the elderly: a 5-year longitudinal study. Oral Surg Oral Med Oral Pathol Oral Radiol 117:716–721CrossRefPubMedGoogle Scholar
  33. 33.
    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457CrossRefGoogle Scholar
  34. 34.
    Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Beck DJ, Taylor GW, Borgnakke WS, Page RC, Genco RJ (2013) Self-reported measures for surveillance of periodontitis. J Dent Res 92:1041–1047CrossRefPubMedGoogle Scholar
  35. 35.
    Slade GD, Spencer AJ (1994) Development and evaluation of the Oral Health Impact Profile. Community Dent Health 11:3–11PubMedGoogle Scholar
  36. 36.
    Mandel ID, Wotman S (1976) The salivary secretions in health and disease. Oral Sci Rev 8:25–47PubMedGoogle Scholar
  37. 37.
    Ramseier CA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, Rayburn LA, Tran HM, Singh AK, Giannobile WV (2009) Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 80:436–446CrossRefPubMedGoogle Scholar
  38. 38.
    Mamounas EP, Jeong JH, Wickerham DL, Smith RE, Ganz PA, Land SR, Eisen A, Fehrenbacher L, Farrar WB, Atkins JN, Pajon ER, Vogel VG, Kroener JF, Hutchins LF, Robidoux A, Hoehn JL, Ingle JN, Geyer CE Jr, Costantino JP, Wolmark N (2008) Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 trial. J Clin Oncol 26:1965–1971CrossRefPubMedGoogle Scholar
  39. 39.
    Streckfus CF, Baur U, Brown LJ, et al. (1998) Effects of estrogen status and aging on salivary flow rates in healthy Caucasian women. Gerontology 44:32–39CrossRefPubMedGoogle Scholar
  40. 40.
    Jensen SB, Mouridsen HT, Reibel J, Brünner N, Nauntofte B (2008) Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncol 44:162–173Google Scholar
  41. 41.
    LaMonte MJ, Hovey KM, Millen AE, Genco RJ, Wactawski-Wende J (2014) Accuracy of self-reported periodontal disease in the Women's Health Initiative observational study. J Periodontol 85:1006–1018CrossRefPubMedGoogle Scholar
  42. 42.
    Taichman LS, Griggs JJ, Inglehart MR (2015) Periodontal health, perceived oral health, and dental care utilization of breast cancer survivors. J Public Health Dent 75:148–156CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Dawes C, Pedersen AM, Villa A, et al. (2015) The functions of human saliva: a review sponsored by the World Workshop on Oral Medicine VI. Arch Oral Biol 60:863–874CrossRefPubMedGoogle Scholar
  44. 44.
    Locker D (2003) Dental status, xerostomia and the oral health-related quality of life of an elderly institutionalized population. Spec Care Dentist 23:86–93CrossRefPubMedGoogle Scholar
  45. 45.
    Rhodus NL, Brown J (1990) The association of xerostomia and inadequate intake in older adults. J Am Diet Assoc 90:1688–1692PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • L. Susan Taichman
    • 1
  • Catherine H. Van Poznak
    • 2
  • Marita R. Inglehart
    • 3
  1. 1.Department of Periodontics and Oral Medicine, School of DentistryUniversity of MichiganAnn ArborUSA
  2. 2.Department of Internal Medicine, Hematology and Oncology DivisionUniversity of MichiganAnn ArborUSA
  3. 3.Department of Periodontics and Oral Medicine, School of Dentistry & Department of Psychology, College of Literature, Science & ArtsUniversity of MichiganAnn ArborUSA

Personalised recommendations